Security key
640268108
NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)
CUSIP: 640268108
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 169,134,728
- Total 13F value
- $382,214,358
- Share change
- -7,012,774
- Put/Call ratio
- 90%
- SEC-reported price per share
- $2.26
- Number of holders
- 209
- Value change
- -$28,072,203
- Number of buys
- 92
- Number of sells
- 98
- Shares outstanding
- 29,109,163
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2022
Institutions
209
Top holders
10
NKTR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
NEKTAR THERAPEUTICS SEC filings
NEKTAR THERAPEUTICS company facts
Broader feeds
Reporting periods
Holder history for CUSIP 640268108
Recent filing periods:
Ownership snapshot
Top reported holders of NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Invesco Ltd.
Disclosed value leader
Invesco Ltd.
Comparable rows
15/15
Latest evidence
30 Sep 2022
13F
Lead comparable stake: 128%
Showing 1-6 of 15 holder rows.
Quick read
Invesco Ltd. leads the comparable SEC ownership view at 128%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Invesco Ltd.'s linked filing trail.
Comparable ownership
Top 5
Invesco Ltd.
128%
BlackRock Finance, Inc.
120%
VANGUARD GROUP INC
80%
PRIMECAP MANAGEMENT CO/CA/
56%
WELLINGTON MANAGEMENT GROUP LLP
39%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Invesco Ltd. |
13F
Company
|
128%
|
$119,244,000
37,263,641 shares
|
— | 30 Sep 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
120%
|
$112,159,000
35,050,519 shares
|
— | 30 Sep 2022 |
| VANGUARD GROUP INC |
13F
Company
|
80%
|
$74,128,000
23,164,944 shares
|
— | 30 Sep 2022 |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
56%
|
$52,552,000
16,422,443 shares
|
— | 30 Sep 2022 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
39%
|
$36,428,000
11,383,721 shares
|
— | 30 Sep 2022 |
| STATE STREET CORP |
13F
Company
|
27%
|
$25,142,000
7,856,892 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
209
Shares
169,134,728
Rows available
209
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q1 2026 Across Filers
Q1 2026 holders
7
Q4 2022 holders
209
Holder diff
202
| Investor | Q1 2026 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q1 2026 value | Q4 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend